Nonclassical MHC-dependent Innate T Cell Ontogeny and Function in the Amphibian Xenopus
两栖类非洲爪蟾非经典 MHC 依赖性先天 T 细胞个体发育和功能
基本信息
- 批准号:1456213
- 负责人:
- 金额:$ 66.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Continuing Grant
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-01 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
T cells are well known for their role in generating the capacity of the adaptive immune system to identify and respond to diverse non-self antigens. The selectivity of a T cell arises from the T cell receptor variant it displays at its surface, with an individual?s T cell population containing a massive repertoire of distinct T cell receptor variants. However, a subgroup of T cells displays a limited or invariant set of T cell receptors. These so called innate T cells (iT cells) are thought to be rapid responders to infections, recognizing via their T cell receptors conserved molecular determinants in pathogens and providing defense in advance (or absence) of an adaptive immune response. However little is known about how iT cells differentiate or the role they play in immune responses. With preliminary data demonstrating that iT cells are well represented in tadpoles of the frog Xenopus, this project addresses the general hypothesis that the external development of tadpoles requires a capacity to mount rapid immune responses to viruses and bacteria, that the responses be mediated by a small population of immune competent cells, and that these requirements are met by iT cells. This research will extend our understanding of the evolution, biology and importance of iT cells in host/pathogen interactions. It also has the potential to suggest immunologically informed strategies for controlling pathogens and their role in amphibian decline. Undergraduate, graduate and post-graduate students will be extensively involved in all aspects of the research, which includes opportunities to study fundamental immunology, development, microbiology and evolution, as well as to learn a range of modern molecular, cellular and reverse genetic techniques. The PI will recruit one or two undergraduate students during the academic year, and in collaboration with the NSF BIO REU program and the Summer Undergraduate Research Program, at least one additional minority undergraduate each summer. The PI also directs the Xenopus laevis Research Resource for Immunobiology, which provides reagents, animals, information, assistance, training and outreach to scientists and the public.Two specific hypotheses guide this project: (i) ectothermic vertebrates with rapid external development critically rely on iT cells for an innate-like T cell repertoire; and (ii) that class Ib restricted iT cells are pivotal in orchestrating immune responses against viral and bacterial pathogens. This hypothesis will be addressed in vivo in X. laevis tadpoles and adults with innovative reverse genetic loss-of-function approaches that combine transgenesis with RNAi or CRISPr/Cas genome editing technologies to determine the roles of class Ib molecules in the development and function of iT cells in X. laevis. The research will also use and further develop class Ib tetramers and antibodies to identify distinct iT cell subsets. The specific aims are: (1) To identify and characterize class Ib genes regulating the development and function of distinct iT cell lineages using qPCR, immunohistology and in situ hybridization as well as class Ib-deficient transgenic lines; (2) To characterize distinct class Ib-restricted iT cell lineages in tadpoles and adults using a combination of class Ib tetramers and monoclonal antibodies with flow cytometry, cell sorting and fluorescence microscopy; (3) To elucidate the roles of distinct class Ib-restricted iT cell lineages of tadpoles and adults in vivo during immune response against ecologically relevant pathogens including the ranavirus Frog virus 3, Mycobacterium marinum, and Aeromonas hydrophila. The successful application of tools (class Ib tetramers and antibodies) and innovative loss-of-function by transgenesis technologies will further empower the Xenopus research model.
T细胞以其在产生适应性免疫系统识别和响应各种非自身抗原的能力方面的作用而闻名。 T细胞的选择性来自其表面显示的T细胞受体变体,其中一个个体的T细胞种群包含大量的T细胞受体变体的大量曲目。但是,T细胞的一个亚组显示了一组有限或不变的T细胞受体。这些所谓的先天T细胞(IT细胞)被认为是对感染的快速反应者,通过其T细胞受体保守的病原体中保守的分子决定因素,并提前(或不存在)适应性免疫反应。然而,关于IT细胞如何区分或它们在免疫反应中起作用的作用知之甚少。通过初步数据,表明IT细胞在青蛙爪蟾的t骨中得到很好的表示,该项目解决了以下一般假设:t的外部发育需要能够实现对病毒和细菌的快速免疫反应的能力,而反应是由少量的免疫胜任细胞介导的,并且这些需求符合这些需求,并且这些需求是由IT细胞满足的。这项研究将扩展我们对宿主/病原体相互作用中IT细胞的进化,生物学和重要性的理解。它还有可能提出免疫学知情的策略来控制病原体及其在两栖动物衰落中的作用。本科,研究生和研究生将广泛参与研究的各个方面,其中包括研究基本免疫学,发展,微生物学和进化的机会,以及学习一系列现代分子,细胞和反向遗传技术。 PI将在学年期间招募一两个本科生,并与NSF Bio REU计划和夏季本科研究计划合作,每年夏天至少有一个少数少数族裔本科生。 PI还指导Xenopus laevis免疫生物学研究资源,该研究资源为科学家和公众提供试剂,动物,信息,辅助,培训和外展。两个特定的假设指导该项目:(i)敏捷的外部发育迅速依赖于IT的快速外部发育,以使IT细胞依赖于先天性的T Cell Ectertoire; (ii)IB类限制IT细胞在策划针对病毒和细菌病原体的免疫反应方面至关重要。该假设将在X. laevis t和成年人中的体内解决,具有创新的反向遗传功能丧失方法,这些方法将转世与RNAi或Crispr/Caspr/Caspr/Caspr/Caspr/Caspr/Caspr/Caspr/Caspr/Caspr/Caspr/cas genome编辑技术确定,以确定IB类分子在X. laevis中IT细胞开发和功能中的作用。这项研究还将使用并进一步开发IB类四聚体和抗体来识别不同的IT细胞子集。具体目的是:(1)识别和表征IB类基因,使用QPCR,免疫组织学和原位杂交以及IB类缺乏的转基因线来调节不同IT细胞谱系的发育和功能; (2)使用IB类四聚体和单克隆抗体与流式细胞仪,细胞分配和荧光显微镜的组合来表征t和成年人中不同类IB限制的IT细胞谱系; (3)在免疫反应期间,促t和成年人在体内对生态相关病原体(包括ranavirus frog病毒3,虫害菌群和空气果中的生态相关病原体)的不同生态相关病原体的体内t和成年人在体内的角色的作用。转基因技术的工具(IB类四聚体和抗体)的成功应用以及创新的功能丧失将进一步增强Xenopus研究模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jacques Robert其他文献
Bidding for Firms : An Asymmetric Auction Model of Interjurisdictional Competition
企业招标:跨辖区竞争的不对称拍卖模型
- DOI:
- 发表时间:
2000 - 期刊:
- 影响因子:0
- 作者:
Laurent Martin;Peter Cramton;Robert Schwab;Lawrence M. Ausubel;Wallace Oates;Gregory Besharov;John Conley;William Hoyt;Scott Page;David Wildasin;Gary Biglaiser;P. Jehiel;B. Moldovanu;Tomas Philipson;Jacques Robert;Jesse Schwartz - 通讯作者:
Jesse Schwartz
Purification and characterization of cytoplasmic creatine kinase isozymes ofXenopus laevis
非洲爪蟾细胞质肌酸激酶同工酶的纯化和表征
- DOI:
10.1007/bf02399600 - 发表时间:
1988 - 期刊:
- 影响因子:2.4
- 作者:
Jacques Robert;Hans Rudolf Kobel - 通讯作者:
Hans Rudolf Kobel
Biosynthesis of an aminopiperidino metabolite of irinotecan [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine] by human hepatic microsomes.
人肝微粒体生物合成伊立替康的氨基哌啶代谢物 [7-乙基-10-[4-(1-哌啶基)-1-哌啶基]羰氧基喜树碱]。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:3.9
- 作者:
M. Haaz;Christian Riché;L. Rivory;Jacques Robert - 通讯作者:
Jacques Robert
A phase II study for the evaluation of quinine as a modulator of multidrug resistance in non-Hodgkin’s lymphoma
- DOI:
10.1016/j.ejca.2005.11.044 - 发表时间:
2007-01-01 - 期刊:
- 影响因子:
- 作者:
Pierre Soubeyran;Amine Masmoudi;Christelle Blanc-Bisson;Ricardo Bellott;Isabelle Soubeyran;Catherine Donamaria;Matthieu Molimard;Nathalie Quénel;Bernard Hœrni;Jacques Robert - 通讯作者:
Jacques Robert
Série Scientifique Scientific Series Using Ex Ante Payments in Self-enforcing Risk-sharing Contracts Les Organisations-partenaires / the Partner Organizations Using Ex Ante Payments in Self-enforcing Risk-sharing Contracts
Série Scientifique 科学系列 在自我执行风险分担合同中使用事前付款 Les Organizations-partenaires / 在自我执行风险分担合同中使用事前付款的合作伙伴组织
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Céline Gauthier;Michel Poitevin Montréal;Polytechnique;P. Beaudry;Jim Brander;C. Bronsard;T. Chung;Bentley Macleod;Jacques Robert;M. Poitevin - 通讯作者:
M. Poitevin
Jacques Robert的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jacques Robert', 18)}}的其他基金
Collaborative Research: IntBIO: The Evolution of Immune Investment Strategies Across Amphibian Ontogeny
合作研究:IntBIO:跨两栖动物个体发育的免疫投资策略的演变
- 批准号:
2316470 - 财政年份:2023
- 资助金额:
$ 66.5万 - 项目类别:
Standard Grant
Roles of Macrophages in Immunity to Ranavirus, and in Viral Persistence and Dissemination
巨噬细胞在蛙病毒免疫以及病毒持续和传播中的作用
- 批准号:
1754274 - 财政年份:2018
- 资助金额:
$ 66.5万 - 项目类别:
Continuing Grant
Meeting: 3rd North American Comparative Immunology Workshop, University of Rochester Medical Center, Rochester NY, June 6-8, 2012
会议:第三届北美比较免疫学研讨会,罗彻斯特大学医学中心,纽约州罗彻斯特,2012 年 6 月 6-8 日
- 批准号:
1203147 - 财政年份:2012
- 资助金额:
$ 66.5万 - 项目类别:
Standard Grant
Interaction of the Xenopus Immune System with an Emerging Ranavirus Pathogen
非洲爪蟾免疫系统与新兴蛙病毒病原体的相互作用
- 批准号:
0923772 - 财政年份:2009
- 资助金额:
$ 66.5万 - 项目类别:
Standard Grant
Immune Responses to Emerging Ranavirus In Xenopus
非洲爪蟾对新出现的蛙病毒的免疫反应
- 批准号:
0445509 - 财政年份:2005
- 资助金额:
$ 66.5万 - 项目类别:
Continuing Grant
CD8 NK/T Cells and the Phylogeny of Cellular Immunity
CD8 NK/T 细胞和细胞免疫的系统发育
- 批准号:
0136536 - 财政年份:2002
- 资助金额:
$ 66.5万 - 项目类别:
Continuing Grant
相似国自然基金
钩吻素子对胃癌MHC-I类抗原呈递激活免疫应答的调控及其机制研究
- 批准号:82373138
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
KIF17介导肿瘤细胞MHC-II胞膜定位促进乳腺癌抗原提呈及免疫应答的机制研究
- 批准号:82372781
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
基于MHC-II/CD72/Sema4D轴调控神经元-T细胞通讯探讨知母黄柏药对防治糖尿病脑病神经免疫调节机制
- 批准号:82304909
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
耐受性DC通过Wnt5a信号通路调控MHC-II+CD8+Treg诱导免疫耐受的机制研究
- 批准号:82370665
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向TRIM24通过促进三阴性乳腺癌MHC-I表达增强免疫治疗疗效的研究
- 批准号:82372783
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Characterization of disulfide modified diabetogenic neoepitopes
二硫键修饰的糖尿病新表位的表征
- 批准号:
10720644 - 财政年份:2023
- 资助金额:
$ 66.5万 - 项目类别:
Mechanisms and consequences of antigen-dependent T cell homing for adoptive immunotherapies
过继免疫疗法中抗原依赖性 T 细胞归巢的机制和后果
- 批准号:
10654215 - 财政年份:2023
- 资助金额:
$ 66.5万 - 项目类别:
Pathogenic B cell:CD4 T cell interactions in a novel B cell-dependent EAE mouse model of multiple sclerosis
致病性 B 细胞:CD4 T 细胞在新型 B 细胞依赖性多发性硬化症 EAE 小鼠模型中的相互作用
- 批准号:
10718277 - 财政年份:2023
- 资助金额:
$ 66.5万 - 项目类别:
Thymic selection abnormalities in Type 1 Diabetes
1 型糖尿病的胸腺选择异常
- 批准号:
10717714 - 财政年份:2023
- 资助金额:
$ 66.5万 - 项目类别:
Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma
纤维板层肝细胞癌的新抗原特异性 T 细胞反应
- 批准号:
10609918 - 财政年份:2023
- 资助金额:
$ 66.5万 - 项目类别: